pre-ipo
Stage
2015
Founded
1
Investors
About
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company developing a new class of immuno-oncology agents that combine antibody targeting with activation of innate and adaptive immune responses to treat cancer.
Explore Bolt Biotherapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.